Evidence map›Paper›PMID 39158577›Full record

ArticleJournal of the American Heart Association2024

Electrophysiological Mechanism of Catestatin Antiarrhythmia: Enhancement of

Ying Zhang, Hua Chen, Qingmin Ma, Hui Jia, Hongyu Ma, Zishuo Du, Yan Liu, Xiangjian Zhang, Yi Zhang, Yue Guan and 1 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Catestatin in Cardiovascular Diseases.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ying ZhangDepartment of Physiology Hebei Medical University Shijiazhuang Hebei China.ORCID 0000-0002-8850-9682
Hua ChenDepartment of Cardiovascular Care Unit Hebei General Hospital Shijiazhuang Hebei China.ORCID 0000-0002-0395-266X
Qingmin MaDepartment of Ophthalmology Hebei General Hospital Shijiazhuang Hebei China.
Hui JiaDepartment of Physiology Hebei Medical University Shijiazhuang Hebei China.ORCID 0009-0004-4417-7809
Hongyu MaDepartment of Physiology Hebei Medical University Shijiazhuang Hebei China.ORCID 0000-0002-4918-5195
Zishuo DuDepartment of Physiology Hebei Medical University Shijiazhuang Hebei China.ORCID 0009-0001-3189-0275
Yan LiuDepartment of Endocrinology The Third Hospital of Hebei Medical University Shijiazhuang Hebei China.ORCID 0000-0003-4097-8049
Xiangjian ZhangHebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease Shijiazhuang Hebei China.ORCID 0000-0003-0114-1668
Yi ZhangDepartment of Physiology Hebei Medical University Shijiazhuang Hebei China.
Yue GuanDepartment of Physiology Hebei Medical University Shijiazhuang Hebei China.ORCID 0009-0001-6075-5144
Huijie MaDepartment of Physiology Hebei Medical University Shijiazhuang Hebei China.ORCID 0000-0002-6069-349X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular disease remains one of the leading causes of death globally. Myocardial ischemia and infarction, in particular, frequently cause disturbances in cardiac electrical activity that can trigger ventricular arrhythmias. We aimed to investigate whether catestatin, an endogenous catecholamine-inhibiting peptide, ameliorates myocardial ischemia-induced ventricular arrhythmias in rats and the underlying ionic mechanisms. METHODS AND

resultsAdult male Sprague-Dawley rats were randomly divided into control and catestatin groups. Ventricular arrhythmias were induced by ligation of the left anterior descending coronary artery and electrical stimulation. Action potential, transient outward potassium current, delayed rectifier potassium current, inward rectifying potassium current, and L-type calcium current (

conclusionsCatestatin enhances the activity of transient outward potassium current, delayed rectifier potassium current, and inward rectifying potassium current, while suppressing the

Indexed as

Action PotentialsChromogranin AMyocytes, CardiacPeptide FragmentsRats, Sprague-DawleyAnimalsAnti-Arrhythmia AgentsArrhythmias, CardiacCalcium Channels, L-TypeDelayed Rectifier Potassium ChannelsDisease Models, AnimalHeart VentriclesMalePatch-Clamp TechniquesPotassium Channel BlockersPotassium ChannelsAnti-Arrhythmia AgentsCalcium Channels, L-TypeChromogranin Achromogranin A (344-364)Delayed Rectifier Potassium ChannelsPeptide FragmentsPotassium Channel BlockersPotassium ChannelsPotassium Channels, Inwardly Rectifyingaction potentialarrhythmiacatestatinL‐type calcium channelpotassium channel

Identifiers

PMID39158577
PMCPMC11963934

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.